Details for New Drug Application (NDA): 208424
✉ Email this page to a colleague
The generic ingredient in GONITRO is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 208424
Tradename: | GONITRO |
Applicant: | Pohl Boskamp |
Ingredient: | nitroglycerin |
Patents: | 1 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 208424
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;SUBLINGUAL | Strength | 0.4MG/PACKET | ||||
Approval Date: | Jun 8, 2016 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 11, 2032 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription